Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Tsangaris, Iraklis ^a   Plachouras, Diamantis ^a   Kavatha, Dimitra ^a   Gourgoulis, George M ^a   Tsantes, Argirios ^a   Kopterides, Petros ^a   Tsaknis, George ^a   Dimopoulou, Ioanna ^a   Orfanos, Stylianos ^a   Giamarellos Bourboulis, Evangelos ^a   Giamarellou, Helen ^a   Armaganidis, Apostolos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; FEVER; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AREA UNDER THE CURVE; BACTERIAL INFECTION; BLOOD; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; FEMALE; FEVER; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 74049089717     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-213     Document Type: Article

References (30)

1. Montuclard L, Garrouste-Orgeas M, Timsit JF, Misset B, De Jonghe B, Carlet J. Outcome, functional autonomy, and quality of life of elderly patients with a long-term intensive care unit stay. Crit Care Med 2000, 28:3389-3395. 10.1097/00003246-200010000-00002, 11057791.
2. Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A. Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest 1998, 114:192-198. 10.1378/chest.114.1.192, 9674469.
3. Laupland K, Kirkpatrick AW, Kortbeek JB, Zuege DJ. Long-term mortality outcome associated with prolonged admission to the ICU. Chest 2006, 129:954-9. 10.1378/chest.129.4.954, 16608944.
4. Olaechea PM, Ulibarrena MA, Alvarez-Lerma F, Insausti J, Palomar M. Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit. Infect Control Hosp Epidemiol 2003, 24:207-13. 10.1086/502191, 12683514.
5. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005, 33:2184-2193. 10.1097/01.CCM.0000181731.53912.D9, 16215368.
6. Dimick JB, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter related bloodstream infection in the surgical intensive care unit. Arch Surg 2001, 136:229-234. 10.1001/archsurg.136.2.229, 11177147.
7. Kalb T, Lorin S. Infection in the chronically critically ill: unique risk profile in a newly defined population. Critical Care Clinics 2002, 3:529-552.
8. Tang B, Eslick G, Craig J, McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-17. 10.1016/S1473-3099(07)70052-X, 17317602.
9. Uzzan B, Cohen R, Nicholas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003. 10.1097/01.CCM.0000226413.54364.36, 16715031.
10. Christ-Crain M, Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Lancet 2004, 363:600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
11. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84-93. 10.1164/rccm.200512-1922OC, 16603606.
12. Nobre V, Stephan Harbarth S, Graf J, Rohner P, Pugin J. Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients. Am J Respir Crit Care Med 2007, 177:498-505. 10.1164/rccm.200708-1238OC, 18096708.
13. Charles PE, Kus E, Aho S, Prin S, Doise JM, Olsson NO, Blettery B, Quenot JP. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infectious Diseases 2009, 9:49. 10.1186/1471-2334-9-49, 2679028, 19386110.
14. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. CRP and PCT as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J
15. Levi MM, Fink MP, Marshall LC, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent JL, Ramsay G. 2001 SCCM/ASICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140. 10.1016/0196-6553(88)90053-3, 2841893.
17. Pearson ML. The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular device-related infections. Am J Infect Control 1996, 24:262-293. 10.1016/S0196-6553(96)90052-8, 8870910.
18. Nakamura A, Wada H, Ikejiri M, Hatada T, Sakurai H, Matsushima Y, Nishioka J, Maruyama K, Isaji S, Takeda T, Nobori T. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 2009, 31:586-91.
19. Ruiz-Alvarez MJ, García-Valdecasas S, De Pablo R, Sanchez García M, Coca C, Groeneveld TW, Roos A, Daha MR, Arribas I. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009, 24:63-71. 10.1177/0885066608327095, 19054806.
20. Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzoti P, Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clinical Biochemistry 2006, 39:1138-1143. 10.1016/j.clinbiochem.2006.08.011, 17052702.
21. Charles PE, Ladoire S, Snauwaert A, Prin S, Aho S, Pechinot A, Olsson NO, Blettery B, Doise JM, Quenot JP. Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis 2008, 8:163. 10.1186/1471-2334-8-163, 2614426, 19055740.
22. Luyt CE, Guérin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005, 171:48-53. 10.1164/rccm.200406-746OC, 15447947.
23. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008, 29:328-333. 10.1097/SHK.0b013e318150716b, 18277855.
24. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602. 10.1097/01.CCM.0000239116.01855.61, 16915118.
25. Charles PE, Tinel C, Barbar S, Aho S, Prin S, Doise JM, Olsson NO, Blettery B, Quenot JP. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 2009, 13:R38. 10.1186/cc7751, 2689475, 19291325.
26. Rapoport J, Teres D, Zhao Y, Lemeshow S. Length of stay data as a guide to hospital economic performance for ICU patients. Med Care 2003, 41:386-397. 10.1097/00005650-200303000-00007, 12618642.
27. Estenssoro E, Reina R, Canales H, Saenz M, Gonzalez F, Aprea M, Laffaire E, Gola V, Dubin A. The distinct clinical profile of chronically critically ill patients: a cohort study. Critical Care 2006, 10:R89. 10.1186/cc4941, 1550940, 16784546.
28. Jensen J, Bettina L, Lars H, Thomas M, Petersen P, Andersen L, Lauritsen A, Hougaard S, Mantoni T, Bømler B, Thornberg K, Thormar K, Løken J, Steensen M, Carl P, Petersen A, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen M, Fjeldborg P, Larsen K, Rossau C, Thomsen C, Østergaard C, Kjær J, Grarup J, Lundgren J. The Procalcitonin And Survival Study (PASS) A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infectious Diseases 2008, 8:91. 10.1186/1471-2334-8-91, 2491622, 18620598.
29. Tavares E, Maldonado R, Ojeda ML, Minano FJ. Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. Clin Diagn Lab Immunol 2005, 12:1085-1093. 1235789, 16148175.
30. Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO, Blettery B. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008, 8:38. 10.1186/1471-2334-8-38, 2289831, 18366777.